The Diagnostic Odyssey: What Healthcare Gets Wrong About Patients

What does it really mean to put the patient at the center of healthcare innovation? In this episode of Med Tech Gurus, we sit down with Stephanie Hunter-Banks of Jazz Pharmaceuticals, a leader in medical learning, patient engagement, and rare disease advocacy. But what makes this conversation truly powerful is that Stephanie doesn't just study the patient journey—she lives it. As a rare disease patient herself, Stephanie brings a deeply personal and professional perspective to how healthcare systems, MedTech companies, and clinicians engage with patients. Her journey—spanning more than two decades without a definitive diagnosis—offers a raw and honest look into what many patients experience but few organizations truly understand. Stephanie shares why scientific innovation alone isn't enough—and how empathy, trust, and meaningful engagement are critical to driving better outcomes. From the challenges of the "diagnostic odyssey" to the importance of resilience, she provides a framework for how healthcare leaders can rethink patient-centricity—not as a buzzword, but as a real partnership. We also explore the role of medical affairs in translating complex science into real-world clinical decisions, the gaps that still exist between providers and patients, and how leaders can build teams grounded in trust, connection, and growth. If you're interested in rare disease, patient engagement, medical affairs, healthcare leadership, or MedTech innovation, this episode delivers a powerful reminder: the future of healthcare isn't just about better technology—it's about better understanding the people it serves.